Skip to main content

Your search for “Gastroenterology” returned 113 results

UC San Diego Named Among World’s Top 20 Universities by U.S. News & World Report

October 27, 2022

The University of California San Diego has been ranked among the top 20 universities in the world, according to U.S. News & World Report’s 2022-2023 Best Global Universities.

UC San Diego Health System Ranks No. 1

July 16, 2013

UC San Diego Health System is once again ranked among the nation’s best in U.S. News & World Report’s 2013-14 “America’s Best Hospitals” issue. The magazine placed UC San Diego Health System No. 1 in the San Diego metropolitan area with national rankings in 10 specialties.

UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center

February 8, 2016

Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego…

Novel 3D Imaging Offers New Tool for Identifying Advanced Fibrosis in Liver

April 5, 2016

…The American Journal of Gastroenterology, researchers at University of California, San Diego School of Medicine conducted a prospective study of 100 patients (56 percent women) with biopsy-proven NAFLD to assess the efficacy of two-dimensional magnetic resonance elastography (MRE) and a novel 3D version. They found that both MRE technologies were…

UC San Diego Health Ranks #1 by U.S. News & World Report

August 2, 2016

Ranked No. 1 in San Diego, UC San Diego Health and its hospitals have been recognized among the best in the nation by U.S. News & World Report for 2016-17. The annual U.S. News & World Report “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health…

Gastrointestinal Hormone Measurably Improved Symptoms of Non-Alcoholic Fatty Liver Disease

March 8, 2018

Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and…

Study Finds Psoriasis Drug Significantly Effective in Treating Crohn’s Disease

November 16, 2016

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn’s disease. Results of the clinical trial will appear in the November 16 issue of the New England…

UC San Diego’s ‘Proof-of-Concept’ Awards Move Campus Health Innovations to Market

July 13, 2018

Nine teams of UC San Diego students, faculty and other researchers who have developed novel innovations that could improve various aspects of health care, have been awarded proof-of-concept awards designed to help bring their campus inventions to commercial use.

UC San Diego Health Ranks #1 by U.S. News & World Report

July 20, 2015

Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.

(Re)introducing John

February 23, 2023

Get to know the rich history and future plans of new vice chancellor for Health Sciences, John M. Carethers.

Category navigation with Social links